Imexpharm Corporation (CÔNG TY CP DƯỢC PHẨM IMEXPHARM) is a publicly held joint stock company established in 2001 and headquartered at No. 4, Road 30/4, Ward 1, Cao Lanh City, Dong Thap Province, Vietnam. It is registered under business ID and tax code 1400384433 and listed on the Ho Chi Minh Stock Exchange with the ticker IMP. The company specializes in the manufacture of pharmaceuticals, medicinal chemical and botanical products.
Its leadership team includes Mr. Sung Minwoo (Chairman), Ms. Tran Thi Dao (General Director), and Mr. Huynh Van Nhung (Deputy General Director). The company employs 1,446 staff across its head office and key branches in Ho Chi Minh City, Hanoi, and An Giang.
In 2023, Imexpharm earned USD 81.92 million in revenue and USD 12.31 million in profit. It reported total assets of USD 98.3 million and owner's equity of USD 85.64 million. The company’s strong financial structure, a working capital of over USD 36.94 million, and 34.01% year-on-year profit growth reflect strategic investment and prudent financial management.
Its export readiness and compliance with international standards position it for further regional market penetration.
Legal Profile
IMEXPHARM CORPORATION
CÔNG TY CP DƯỢC PHẨM IMEXPHARM
IMEXPHARM
1400384433
01 Aug 2001
Dong Thap Province Department of Finance
IMP
Publicly held
Active
Unlock
Bulk data files, or bulk reports, per sector, location, or even revenue based
Legal Profile
Contact and Location
Legal Representative
Shareholders
Business Operation
Assets
Owner's Equity
Sales
Profit
Company Standard Report
Legal Profile
Business Locations
Legal Representative
EBT
EBITDA
Working Capital
Tangible Net Worth
Financial Ratios
Balance Sheet
Profit and Loss Statement
Cash Flow Statement
Comprehensive Report
Report Summary
Legal Profile
Historical Information
Business Locations
Subsidiary and Affiliated Company
Management and Directors
Shareholders
Business Operation
Suppliers
Buyers
Credit Limit
Industry Information
Key Industry Players
Competitors
Negative Payment Records
Banking Information
Litigation Records; Negative News
Financial Ratios
Balance Sheet
Profit and Loss Statement
Cash Flow Statement
Opinion from Analysts
GET IN TOUCH FOR EXCLUSIVE DEALS!
Reach out to us here for a customized service package or sign up for a better price
We respect your privacy while serving the community. Misusing information for unsolicited contact is strictly prohibited.
To hide this information, please follow the steps below and complete CAPTCHA verification.
Your name *
Email *
Reason for hiding information *
We use cookies to learn about your activities on our website to improve the quality of our services.
We take your privacy very seriously. Please see our Privacy Policy for details and any questions.
Notification
The website is currently being updated. Please check back later. Thank you for your patience!
